Current Ratio in % of HCW Biologics Inc. from Q1 2022 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
HCW Biologics Inc. quarterly Current Ratio history and growth rate from Q1 2022 to Q3 2025.
  • HCW Biologics Inc. Current Ratio for the quarter ending September 30, 2025 was 10.9 %, a 51.7% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)

HCW Biologics Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 10.9 -11.7 -51.7% Sep 30, 2025
Q2 2025 11.1 -45.7 -80.5% Jun 30, 2025
Q1 2025 11 -133 -92.4% Mar 31, 2025
Q4 2024 17 -284 -94.4% Dec 31, 2024
Q3 2024 22.7 -538 -96% Sep 30, 2024
Q2 2024 56.8 -730 -92.8% Jun 30, 2024
Q1 2024 144 -1.02K -87.7% Mar 31, 2024
Q4 2023 301 -1.43K -82.6% Dec 31, 2023
Q3 2023 560 -1.41K -71.6% Sep 30, 2023
Q2 2023 786 -1.36K -63.4% Jun 30, 2023
Q1 2023 1.17K -115 -8.94% Mar 31, 2023
Q4 2022 1.73K Dec 31, 2022
Q3 2022 1.97K Sep 30, 2022
Q2 2022 2.15K Jun 30, 2022
Q1 2022 1.28K Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.